SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against GERON CORPORATION and Its Board of Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action
Against GERON CORPORATION and Its Board of Directors and a Lead Plaintiff
Deadline of May 13, 2014 -- GERN

NEW YORK, April 4, 2014 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a
class action lawsuit has been commenced in the United States District Court
for the Northern District of California on behalf of investors who purchased
Geron Corporation ("Geron" or the "Company") (Nasdaq:GERN) common stock
between June 16, 2013 to March 11, 2014.

For more information, click here: http://zlk.9nl.com/geron-gern.

The complaint alleges that Geron misrepresented and/or failed to disclose
that: (a) persistent low-grade liver function test abnormalities had been
observed in the Phase 2 study of its drug imetelstat in essential
thrombocythemia or polycythemia vera patients; (b) there was a high risk of
potential chronic liver injury following long-term exposure to the drug, and
(c) as a result of the foregoing, defendants' positive statements about the
prospects for imetelstat lacked a reasonable basic and/or were materially
false and misleading.

On March 12, 2014, the Company announced it had received a verbal notice from
the U.S. Food and Drug Administration ("FDA") that its Investigational New
Drug (IND) application for imetelstat had been placed on full clinical hold.
On this news, shares of Geron stock plunged over 60% to close at $1.69 per
share, on extremely heavy volume.

If you suffered a loss in Geron you have until May 13, 2014 to request that
the Court appoint you as lead plaintiff. Your ability to share in any recovery
doesn't require that you serve as a lead plaintiff. To obtain additional
information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or
by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/geron-gern.

Levi & Korsinsky is a national firm with offices in New York, New Jersey,
Connecticut and Washington D.C. The firm's 26 attorneys have extensive
expertise in prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and shareholder
lawsuits. For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Joseph Levi, Esq.
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free: (877) 363-5972
         Fax: (212) 363-7171
         www.zlk.com
 
Press spacebar to pause and continue. Press esc to stop.